Article
Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jul 2009
Huang Shihai, Erickson Brian, Tang Ning, Mak Wai-Bing, Salituro John, Robinson John, Abravaya Klara
Abstract excerpt
BACKGROUND: Abbott RealTime High Risk (HR) HPV is a recently developed test for the detection of 14 high-risk oncogenic HPV types combined with the ability to concurrently identify genotypes 16 and 18. OBJECTIVES: The clinical performance of the Abbott RealTime HR HPV test was evaluated in comparison with the Hybrid Capture 2 (HC2) test for the detection of cervical intraepithelial neoplasia 2 or worse (CIN2+)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
